Pfizer Opens First Drug-Making Plant In China In 20 Years
This article was originally published in PharmAsia News
Executive Summary
Pfizer has opened its first new manufacturing plant in China in 20 years, this one to allow it to nearly triple production of cephalosporin vials of antibiotic. The company intends to make the plant in Northeast China one of its major global suppliers of drugs. Pfizer invested $6 million in the expansion, but overall cost shared with investors was $60.4 million. The plant, opened in 1989, was the first pharmaceutical facility to receive a good manufacturing practices certificate in China. (Click here for more
You may also be interested in...
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.
Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene?
Insurance plans put on notice that CMS is concerned about restrictions on drugs with negotiated prices, but it’s not clear what the agency can or will do about it.